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Mollusk hemocyanins have biomedical uses as carriers/adjuvants and nonspecific
immunostimulants with beneficial clinical outcomes by triggering the production of
proinflammatory cytokines in antigen-presenting cells (APCs) and driving immune
responses toward type 1 T helper (Th1) polarization. Significant structural features of
hemocyanins as a model antigen are their glycosylation patterns. Indeed, hemocyanins
have a multivalent nature as highly mannosylated antigens. We have previously shown
that hemocyanins are internalized by APCs through receptor-mediated endocytosis
with proteins that contain C-type lectin domains, such as mannose receptor (MR).
However, the contribution of other innate immune receptors to the proinflammatory
signaling pathway triggered by hemocyanins is unknown. Thus, we studied the roles
of Dectin-1, Dectin-2, and Toll-like receptor 4 (TLR4) in the hemocyanin activation
of murine APCs, both in dendritic cells (DCs) and macrophages, using hemocyanins
from Megathura crenulata (KLH), Concholepas concholepas (CCH) and Fissurella
latimarginata (FLH). The results showed that these hemocyanins bound to chimeric
Dectin-1 and Dectin-2 receptors in vitro; which significantly decreased when the
glycoproteins were deglycosylated. However, hemocyanin-induced proinflammatory
effects in APCs from Dectin-1 knock-out (KO) and Dectin-2 KO mice were independent
of both receptors. Moreover, when wild-type APCs were cultured in the presence of
hemocyanins, phosphorylation of Syk kinase was not detected. We further showed that
KLH and FLH induced ERK1/2 phosphorylation, a key event involved in the TLR signaling
pathway. We confirmed a glycan-dependent binding of hemocyanins to chimeric TLR4
in vitro. Moreover, DCs from mice deficient for MyD88-adapter-like (Mal), a downstream
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adapter molecule of TLR4, were partially activated by FLH, suggesting a role of the
TLR pathway in hemocyanin recognition to activate APCs. The participation of TLR4
was confirmed through a decrease in IL-12p40 and IL-6 secretion induced by FLH
when a TLR4 blocking antibody was used; a reduction was also observed in DCs from
C3H/HeJ mice, a mouse strain with a nonfunctional mutation for this receptor. Moreover,
IL-6 secretion induced by FLH was abolished in macrophages deficient for TLR4. Our
data showed the involvement of TLR4 in the hemocyanin-mediated proinflammatory
response in APCs, which could cooperate with MR in innate immune recognition of
these glycoproteins.
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INTRODUCTION
Mollusk hemocyanins are extremely large oxygen transport
glycoproteins expressed in gastropods (1, 2). Studies have shown
that hemocyanins -known as classical T-cell-dependent antigens-
inoculated in mammals trigger an immune response that
promotes type 1 T helper (Th1) polarization, which generates
a beneficial immunological bystander effect (3). Due to these
properties, mollusk hemocyanins are used as carriers in antibody
development against hapten molecules and peptides, as well
as carriers/adjuvants in experimental therapeutic vaccines for
cancer (4, 5). By themselves, hemocyanins act as nonspecific
immunostimulants in the postsurgical treatment of superficial
bladder cancer (6). In addition, hemocyanins elicit complement
activation mediated by C1 binding to human natural antibodies
(7). The production of these immunomodulators depends
on direct protein purification from gastropods, with the
most traditionally used hemocyanins for these immunological
applications coming from the gastropod Megathura crenulata,
also known as keyhole limpet hemocyanin [KLH (8)]. Other
alternative hemocyanins have emerged, including those obtained
from the gastropods Concholepas concholepas [CCH (9)]
and Fissurella latimarginata [FLH (10)] from the Chilean
coasts and from Rapana venosa from the Black Sea (RvH),
previously referred to as Rapana thomasiana [RtH (11)], among
others (12, 13).
Hemocyanins are extensively used in clinical and
biotechnological applications because they do not produce
unwanted side effects; however, the mechanisms involved
in their immunomodulatory effects are poorly understood
(3). Understanding those mechanisms will be crucial to
improve the adjuvant and immunostimulant properties
of hemocyanins, which would allow the development of
better vaccines and immunotherapies (14, 15). Different
characteristics have been suggested to explain the immunological
properties of hemocyanins, such as their xenogenicity, large size,
complex quaternary structure, presence of a quasi-symmetrical
arrangement of repetitive epitopes, and glycan moiety content
(16–18). All of these glycoproteins fold as large structures, with
molecular weights ranging from 4 to 8 MDa. The basic structure
comprises ten subunits that self-assemble in pairs to form a
hollow cylinder known as decamer, which can interact to form
didecamers (17, 19, 20). However, isolated subunits of CCH (21)
and RtH (11) also have immunological effects, suggesting that
large size and complex quaternary structure are not the only
factors involved in the immunogenicity and antitumor effect of
these hemocyanins.
In this context, the glycosylation patterns in hemocyanins
have an important role in the stability of their quaternary
structure, supporting the interaction between the hemocyanin
subunits, but these patterns have also been related to their
immunomodulatory effects (18, 22, 23). Mollusk hemocyanins
are highly glycosylated proteins, reaching up to 9% (w/w)
(24). KLH, CCH, and FLH have different N- and O-
glycosylation patterns, with mannose-rich and fucose-rich
N-glycans being the most abundant types (10, 22). KLH
immunization induces cross-reactive antibodies against T
antigen due to the presence of oligosaccharides with the terminal
moiety Gal(β1-3)-GalNAc in its structure (25). Moreover,
sugars on KLH share the structural motif Gal(β1-6)-Man with
side chains on liposaccharide (LPS) from pathogens such
as Salmonella typhimurium and Klebsiella pneumoniae, and
they also induce cross-reactivity with soluble egg antigens
from the parasite Schistosoma mansoni based on fucose-shared
glycans (26–28). Furthermore, sera from mice immunized with
KLH present cross-reactivity with lipoarabinomannan (LAM)
from mycobacteria, the polysaccharide capsule of Cryptococcus
neoformans and LPS from Escherichia coli (29). The MALDI-
TOF-MS oligosaccharide profile of CCH and FLH revealed
abundant diversity in their mannose-rich branched structures
(10). Altogether, these data indicate that mollusk hemocyanins
possess characteristic and heterogeneous glycosylation patterns
and, therefore, could generate different immune responses.
Indeed, the effects of mollusk hemocyanins on antigen-
presenting cells (APCs) are variable. Hemocyanins stimulate
innate immunity by inducing different temporal patterns of
proinflammatory cytokine expression in murine peritoneal
macrophages, leading to a classically activated macrophage (M1)
profile (30). Remarkably, native FLH induces the activation
of murine bone marrow-derived dendritic cells (BMDCs)
with Th1-inducing cytokine expression and enhances major
histocompatibility complex class II (MHC-II) levels (10).
Our current data show that hemocyanins are internalized
by APCs through macropinocytosis and receptor-mediated
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endocytosis in a calcium-dependent manner, which normally
leads to the secretion of proinflammatory cytokines.
However, this cytokine secretion significantly decreased
using deglycosylated FLH, suggesting the participation of
specific glycan receptors in this process (10, 30). APCs have
been described to recognize pathogen-derived glycans through
C-type lectin receptors (CLR) and Toll-like receptors (TLR),
among others, which are able to initiate an immune response
(31). Mannose receptor (MR), a member of the CLR family,
has been identified as a potential receptor for KLH because
the maturation of human dendritic cells (DCs) induced by
this hemocyanin is partially inhibited by anti-MR blocking
antibody (32). In support of this evidence, we performed surface
plasmon resonance studies and showed that KLH, CCH and
FLH directly interact with human MR with high affinity in a
glycan-dependent manner (33). Furthermore, experiments with
the human monocytic THP-1 cell reporter line have shown that
KLH activates the transcription factor NF-κB and this activity is
inhibited by pharmacological inhibitors of Syk or ERK kinases
(34). Therefore, we proposed that different innate immune
receptors are directly stimulated by the glycan moieties on
hemocyanins, giving them a multivalent nature to initiate an
immune response. We hypothesized that the CLRs Dectin-1 and
Dectin-2 as well TLR4 play a role in the hemocyanin-induced
proinflammatory effects. Dectin-1 and Dectin-2 recognize sugars
with β-glucan-rich arrangements or mannose-rich branched
structures from pathogens such as mycobacteria and Schistosoma
mansoni, with some of these sugars existing in hemocyanin
glycosylations (35–38). TLR4 recognizes mycobacteria and LPS
side chains on bacteria such as Salmonella typhimurium or
Escherichia coli; these side chains have also been described to be
similar to hemocyanin glycosylations (29, 39–41).
Here we report that hemocyanin-induced proinflammatory
effects in murine APCs are independent of Dectin-1 and
Dectin-2 despite in vitro KLH, CCH, and FLH binding to
both chimeric receptors. Additionally, we demonstrate that
hemocyanins trigger the TLR signaling pathway in murine APCs
and the main receptor involved is TLR4. These findings open
the possibility for further studies of a potential cooperation of
TLR4 with MR in the hemocyanin-mediated beneficial immune




Hemocyanins from Concholepas concholepas (CCH) and
Fissurella latimarginata (FLH) were provided by Biosonda
Corporation (Santiago, Chile). They were isolated and purified
as described by De Ioannes et al. (9) and Arancibia et al. (10),
respectively, under sterile and endotoxin-free conditions in PBS
(0.1M sodium phosphate, 0.15M NaCl, pH 7.2). To ensure
that the biological effects observed were due to the CCH and
FLH component, as indicated Tynan et al. (42), the endotoxin
content of hemocyanin preparations was determined using a
PyroGene Recombinant Factor C Endotoxin Detection Assay
kit (Lonza Group, Walkersville, MD, USA), and was in a range
of undetectable to 0.48 EU/mg, respectively. Endotoxin-free
hemocyanin (0.5 EU/mg) from Megathura crenulata (KLH) in
PBS was purchased from EMD Millipore (Billerica, MA, USA).
All chemicals were of analytical-grade, and the solutions were
prepared using water for human irrigation (Baxter Healthcare,
Charlotte, NC, USA or Fresenius Kabi, Bad Homburg, Germany)
and filtered through a 0.2µm membrane filter (Millipore,
Billerica, MA, USA). The protein concentration was determined
using the Pierce 660 nm Protein Assay Reagent (Thermo
Scientific, Waltham, MA, USA) according to manufacturer
indications with bovine serum albumin (Thermo Scientific) as
the standard.
Enzymatic and Chemical Hemocyanin
Deglycosylation
Enzymatic N-deglycosylation was performed as described by
Salazar (43). Briefly, 1mg of hemocyanin was diluted in 200 µL
of glycine-NaOH buffer (130mM glycine, pH 8.6) and heated at
60◦C for 15min. Solutions were cooled to room temperature,
and 2 µL of N-glycosidase F (PNGase F; EC 3.5.1.52) 500
mU (CarboClip, Asparia Glycomics, San Sebastian, Spain) were
added. The mixture was incubated for 24 h at 37◦C. Chemical
deglycosylation was performed as described by Arancibia et al.
(44) with modifications. Briefly, hemocyanins (2 mg/mL) were
dissolved in PBS (pH 7.2) containing 15mM sodium periodate
(Merck, Darmstadt, Germany) and incubated for 24 h in the
dark at room temperature. Next, 25 µL of glycerol were added
per 1mL of solution, and the mixtures were incubated for 24 h
in the dark at room temperature. Enzymatically and chemically
deglycosylated hemocyanins were dialyzed against PBS (pH 7.2)
containing 5mM MgCl2 and 5mM CaCl2, concentrated in
Amicon Ultra-15 10K MWCO tubes (Millipore), and filtered
through 0.22-µmmembrane filters (Whatman, Maidstone, UK).
Labeling Hemocyanin With Fluorescent
Dyes
Hemocyanins (KLH, CCH and FLH) were labeled with DyLight
594 NHS Ester Dye (Thermo Scientific) according to the
manufacturer’s instructions. Briefly, 10mg of protein were
diluted in 1mL of 0.2mM PBS/0.1M sodium bicarbonate. Then,
the dye was added and incubated with the proteins for 1 h at
room temperature. The reaction was stopped with 100 µL of
hydroxylamine. Finally, the labeled proteins were concentrated
and washed at least five times with 5mL of PBS at 4◦C using an
Amicon Ultra-4 tube (Millipore). The integrity of the Alexa Fluor
594-labeled hemocyanins was confirmed by SDS-PAGE.
Mice
C57BL/6 wild-type (WT) mice were obtained from Universidad
de Chile (Santiago, Chile) and bred at Biosonda. The study was
performed in strict accordance with the Guidelines for the Care
and Use of Laboratory Animals of the National Commission
for Scientific and Technological Research of Chile (FONDECYT
Project 1151337) and the FUCITED Bioethics Committee.
C57BL/6 Dectin-1 knock-out (KO) and Dectin-2 KO mice were
obtained from Aberdeen University (Aberdeen, UK) and animals
were genotypified by PCR (45, 46). Animal experiments were
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performed using age-matched male mice and conformed to the
animal care and welfare protocols approved by UK Home Office
(project license 70/8073) in compliance with all relevant local
ethical regulations. C57BL/6 Mal KO, C3H/HeN and C3H/HeJ
mice were obtained from Trinity College (Dublin, Ireland). Mice
were housed in the Bioresources Unit in Trinity College Dublin.
Animals were maintained according to the regulations of the
European Union and the Irish Department of Health and all
procedures performed were conducted under animal license
number B100/3321 and were approved by the Trinity College
Dublin Animal Research Ethics Committee (Ethical Approval
Number 091210).
Determination of Hemocyanin Binding to
Chimeric Receptors by ELISA
Hemocyanin binding to the receptors Dectin-1 and Dectin-
2 (Gordon Brown Laboratory, University of Aberdeen), and
TLR4 (Novus Biologicals Centennial, CO, USA) was determined
by ELISA, as described by Royer et al. with modifications
(47). Briefly, polystyrene plates (Thermo Scientific) were treated
overnight at 4◦C with increasing concentrations of native or
deglycosylated hemocyanins (0.5–10µg/mL in PBS, pH 7.2).
For the negative control, the plates were blocked overnight
at 4◦C with PBS containing 0.2% gelatin (Merck) to establish
background binding. Subsequently, the plates were incubated
for 2 h at room temperature with chimeric receptors (Dectin-
1-Fc 2.5µg/mL, Dectin-2-Fc 2µg/mL, and TLR4-Fc 1µg/ml)
diluted in TBS buffer (10mM Tris-HCl, 10mM CaCl2·2H2O,
154mM NaCl and 0.05% Tween-20; pH 7.5). Then, the plates
were incubated for 1 h at room temperature with goat anti-
human IgG serum coupled to alkaline phosphatase (ALP; Sigma-
Aldrich, St. Louis, MO, USA) diluted 1:1,000 in TBS. TBS
washes were performed between each step. Finally, the plates
were incubated for 15min at 37◦C with 1 mg/mL p-nitrophenyl
phosphate (pNPP; Thermo Scientific) in ALP buffer (100mM
Tris-HCl, 100mM NaCl, 1mM MgCl2·6H2O; pH 9.5), and the
optical density was measured at 405 nm in a Synergy HTX ELISA
plate reader (Biotek Instruments, Winooski, VT, USA). The
positive control ligand zymosan A (Sigma-Aldrich) for Dectin-
1, furfurman (InvivoGen, San Diego, CA, USA), a cell wall
preparation from Malassezia furfur for Dectin-2, and LPS from
Escherichia coli serotype R515 (Enzo Life Sciences, Farmingdale,
NY, USA) for TLR4 were used. Gelatin (Merck) was used as
negative control to establish background binding.
Hemocyanin Uptake by NIH3T3 Cells
NIH3T3 cells overexpressing Dectin-1 or Dectin-2 with FcRγ
were used. NIH3T3 cells transfected with empty vector and
overexpressing FcRγ alone were used as control cell lines. Briefly,
2× 105 NIH3T3 cells were incubated with 10µg/mL Alexa Fluor
594-conjugated hemocyanin for 1 h at 37◦C in serum-free media.
Cells were then immediately treated with PBS supplemented
with 10mM EDTA and 4 mg/mL lidocaine (Sigma-Aldrich) and
washed twice with FACS buffer (PBS with 0.5% BSA, 2% FCS,
2mM EDTA) and analyzed on a Fortessa flow cytometer (BD
Biosciences, San Diego, CA, USA).
Cell Culture of Bone Marrow-Derived
Dendritic Cells (BMDCs)
BMDCs were generated as described by Lutz et al. (48). Briefly, 2
× 106 bone marrow cells from C57BL/6, C3H/HeN, or C3H/HeJ
mice were seeded in 10-mm bacteriological culture dishes in
RPMI (HyClone, Logan, Utah, USA) medium supplemented
with 20 ng/mL mouse recombinant GM-CSF (Miltenyi Biotec,
Bergisch Gladbach, Germany) and cultured for 10 days, after
which they were collected via gently pipetting in preparation for
incubation with hemocyanins. For most experiments, BMDCs
were seeded at 1 × 106 cells/mL in 6-well plates and incubated
with the hemocyanins (1 mg/mL each) for 24 h. Then, the
supernatants were collected to measure the cytokine levels,
whereas the cells were treated with PBS supplemented with
10mM EDTA and 4 mg/mL lidocaine and washed twice
with FACS buffer in preparation for the maturation marker
analysis by FACS. LPS from Escherichia coli Serotype R515
(Enzo Life Sciences) and LPS from Salmonella enterica serotype
typhimurium (Sigma-Aldrich) and zymosan A (Sigma-Aldrich),
were used as positive controls; PBS or unstimulated cells were
used as a negative controls. The TLR2 control Pam3CysK4 was
from Invitrogen Life Technologies (Waltham, MA, USA). The
TLR9 control CpG oligonucleotide was fromOligos (Wilsonville,
OR, USA).
Cell Culture of Peritoneal Macrophages
and Immortalized Bone Marrow-Derived
Macrophages (iBMMs)
Peritoneal macrophages from C57BL/6 mice were prepared
according to the method described by Zhang et al. (49), with
some modifications. In brief, mice were injected with 1mL of a
sterile solution of thioglycollate-enriched medium. After 4 days,
the animals were euthanized and immediately injected with 5mL
sterile ice-cold 5mMEDTA in PBS into the peritoneal cavity, and
the peritoneal fluid was collected. Cells were centrifuged at 1,400
rpm twice for 5min, and the pellet was resuspended in RPMI
medium. For most experiments, peritoneal macrophages were
seeded at 1 × 106 cells/mL in 6-well plates and incubated with
hemocyanin (1 mg/mL each) for 24 h. Then, the supernatants
were collected to determine the cytokine levels. The same
controls as listed above were used. iBMMs from C57BL/6 WT
and TLR4 KOmice, which were generated using J2 transforming
retroviruses (expressing Raf and Myc), as described previously
(50), were a gift from Prof. D. Golenbock (University of
Massachusetts Medical Center, USA). iBMMs were seeded at
1.5 × 105 cells/mL in 96-well plates and harvested after 24 h of
incubation with 1 mg/mL FLH. The supernatants were assessed
for cytokine levels. LPS from Escherichia coli serotype R515 (Enzo
Life Sciences) was used as a positive control, and PBS was used as
a negative control.
TLR4 Inhibition With Blocking Antibody
The procedure of Morhidan et al. (51) with modifications was
used. Briefly, BMDCs and peritoneal macrophages grown as
described previously, seeded at a density of 5 × 104 cells
in a volume of 100 µL in 96-well plates, were preincubated
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with 10µg/mL of the blocking rat anti-mouse anti-TLR4/MD-2
monoclonal antibody MTS510 (Thermo Scientific) or 10µg/mL
of rat IgG2a isotype control (Santa Cruz Biotechnology, Dallas,
TX, USA) for 1 h; subsequently, they were stimulated with 1
mg/mL of FLH. As TLR4 agonist positive control, 10 ng/mL LPS
from Escherichia coli serotype R515 (Enzo Life Sciences) was
used. As a negative control, unstimulated cells were used. After
24 h of stimulation, supernatants were assessed for IL-12 p40 and
IL-6 measurements as described below.
Cytokine Determination
Supernatants from BMDCs, peritoneal macrophages and iBMMs
cultures were stored at −20◦C until further analyzed. Levels
of the murine cytokines IL-12p40 and IL-6 were measured
in supernatants in duplicate using commercial kits according
to the manufacturer’s instructions (BD OptEIA ELISA Set,
BD Biosciences).
FACS Analysis of Maturation Markers
Antibodies used for flow cytometry were obtained from
Biolegend (San Diego, CA, USA) unless otherwise indicated and
targeted the following proteins: mouse MHC-I haplotype H-2Kb
(clone AF6-88.5), mouse CD40 (clone 3/23), mouse CD80 (clone
16-10A1), mouse CD86 (clone GL-1) and MHC-II haplotype I-
A/I-E (clone 2G9, BD Biosciences). BMDCs were treated with
PBS supplemented with 10mM EDTA and 4 mg/mL lidocaine
and washed twice with ice-cold FACS buffer (0.5% BSA, 2% FCS,
2mM EDTA in PBS). Cells were incubated cells for 30min on
ice with a FcR blocking antibody (clone 2.4G2, Gordon Brown
Laboratory, University of Aberdeen) using 0.5 µL of antibody
in 100 µL per assay. Then, the cells were incubated with labeled
antibodies (1:100 dilution) for at least 30min on ice and washed
twice with ice-cold FACS buffer. Finally, cells were fixed with
2% paraformaldehyde in PBS and analyzed on a Fortessa flow
cytometer (BD Biosciences).
Pharmacological Inhibition of Syk, ERK1/2,
p38, and JNK
For Syk kinase inhibition, BMDCs fromWTmice were collected,
and seeded at 1 × 106 cells/mL in 6-well plates and pretreated
for 30min with 20µM piceatannol (Enzo Life Sciences) or 1µM
BAY 61-3606 (Enzo Life Sciences) (34, 52). For MAP kinases
inhibition, BMDCs from WT mice were collected, seeded at 1
× 106 cells/mL in 24-well plates and pretreated for 1 h with
the following inhibitors: 100µM FR180204 (Tocris Bioscience,
Bristol, UK) for ERK1/2 (53), 100µM SB203580 (Tocris
Bioscience) for p38 or 20µM SP600125 (Tocris Bioscience)
for JNK (54). Then, BMDCs were incubated with 1 mg/mL
of each hemocyanin for 24 h, and the supernatants were
collected to determine the cytokine levels. The control treatments
were performed with the respective DMSO percentage used
as a vehicle for most inhibitors. The Alamar Blue R© bioassay
(Thermo Scientific), a redox indicator of cell viability, was
used according to the manufacturer’s instructions to assess cell
viability in BMDCs cultures with pharmacological inhibitors
(55). Under the conditions described above, the cell viability
was >80–90%.
Western Blotting Analysis of Syk and
ERK1/2 Activation
First, extracts of 2 × 106 BMDCs cultured with hemocyanins
were prepared. LPS or zymosan A were included as positive
controls, and PBS and untreated medium were included as
negative controls; all cells were treated for the indicated
time period. Cell lysates were prepared with RIPA buffer
supplemented with protease and phosphatase inhibitors. For
Syk kinase analysis, cell lysates were subjected to SDS-
PAGE using a 4–12% gradient gel (NuPAGE Novex Tris-
Bis, Thermo Scientific) for 1 h at 200V (56). Then, proteins
were transferred onto a PVDF membrane (Thermo Scientific)
at 200mA for 1.5 h as described by Towin et al. (57).
The membranes were blocked for 1 h at room temperature
with 5% BSA in TBS containing 0.05% Tween-20 (TBS-T)
and then incubated with primary antibodies diluted in TBS-
T containing 1% BSA overnight at 4◦C as follows: anti-
phospho-Syk (Y525/Y526) (1:1,000; Cell Signaling Technology,
Danvers, MA, USA; clone C87C1), anti-Syk (1:1,000; Abcam,
Cambridge, UK; clone SYK-01) and GAPDH (1:5,000; Cell
Signaling Technology, clone 14C10). Then, membranes were
washed three times with TBS-T and probed for 1 h at room
temperature with an anti-rabbit IgG HRP-conjugated antibody
(1:5,000; Cell Signaling Technology) diluted in 1% BSA for
phospho-Syk and GAPDH and an anti-mouse IgG HRP-
conjugated antibody (1:10,000; Jackson ImmunoResearch, West
Grove, PA, USA) diluted in 1% BSA for Syk. Membranes
were washed and incubated with Femto ECL Western blotting
substrate (Thermo Scientific) for protein band detection.
For ERK1/2 kinase analysis, cell lysates were subjected to
SDS-PAGE using a prepared 12% polyacrylamide gel for
approximately 3 h at 80V. Proteins were transferred onto
a nitrocellulose membrane (Thermo Scientific) at 400mA
for 1.5 h. The membranes were blocked with 5% nonfat
dry milk in TBS-T for 1 h at room temperature and then
incubated overnight at 4◦C with primary antibodies targeting the
following proteins: phospho-ERK1/2 (Thr202/Tyr204) (1:1,000;
Cell Signaling Technology, clone D13.14.4E) and ERK1/2
(1:1,000; Cell Signaling Technology) diluted in TBS-T and
GAPDH (1:1,000; Cell Signaling Technology, clone 14C10)
diluted in 5% nonfat drymilk in TBS-T.Membranes were washed
three times with TBS-T and separately probed for 2 h at room
temperature with anti-rabbit IgG HRP-linked antibody (1:5,000;
Merck) diluted in 5% nonfat dry milk in TBS-T. Finally, the
membranes were washed and incubated with EZ-ECL Western
blotting substrate (Biological Industries, Cromwell, CT, USA) to
detect the protein bands. The densitometry analyses on Western
blotting were assessed using the Un-Scan-It Gel 6.1 program
(Orem, Utah, USA).
Statistical Analysis
The results of the experiments are expressed as the mean ±
SEM. Comparisons between two groups were performed using
the paired or unpaired Student’s t-test. Comparisons between
three or more groups were performed using two-way ANOVA
with Bonferroni posttest. Statistical significance was defined at p
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≤ 0.05. Analyses were performed using GraphPad Prism software
(La Jolla, CA, USA).
RESULTS
Glycans Participate in Hemocyanin Binding
to the CLR Dectin-1 and Dectin-2 in vitro
Considering that hemocyanins are highly glycosylatedmolecules,
containing mannose as a more abundant sugar, we propose
that the recognition of these glycoproteins by APCs is initially
dependent on CLRs, including Dectin-1, the prototypic member
of the family, and Dectin-2, which is one of the receptors that
can recognize mannose-rich branched structures (35–37). Thus,
an indirect ELISAwas developed using increasing concentrations
of native hemocyanins (0.5–10µg/mL) to evaluate the binding of
Fc chimeric Dectin-1 and Dectin-2 receptors. The results showed
that Dectin-1 bound to the three hemocyanins (KLH, CCH and
FLH) with similar intensity (Figures 1A–C, respectively; black
circles). To demonstrate the dependence of this interaction on
glycan, we developed a similar assay using hemocyanins that
were chemically deglycosylated by sodium periodate oxidation
or enzymatically deglycosylated with PNGase F. Hemocyanins
deglycosylated by both methods showed a reduction in binding
to Dectin-1, with the lowest binding observed with N-
deglycosylated hemocyanins (Figures 1A–C; red squares and
blue triangles). The results are summarized in Figure 1D, in
which the binding of hemocyanins to Dectin-1 was analyzed at
a single representative hemocyanin concentration (10µg/mL). A
significant decrease in the binding of chemically deglycosylated
(red bars) and N-deglycosylated (blue bars) with respect to
native hemocyanin (black bars) was observed. Similar results
were obtained for the binding of Dectin-2 to the three
hemocyanins (Figures 1E–G; black circles). Both deglycosylation
treatments tended to reduce Dectin-2 binding. However, only
N-deglycosylated hemocyanins showed a significant reduction
of Dectin-2 binding (Figures 1E–G; blue triangles). Similar to
the abovementioned experiments, the binding of hemocyanins to
Dectin-2 was analyzed at a single representative concentration
(10µg/mL), and a significant effect on N-deglycosylation was
observed for all hemocyanins (Figure 1H, blue bars). These
results strongly supported the carbohydrate-dependent binding
of hemocyanins to Dectin-1 and Dectin-2 in vitro, which led us
to carry out studies using APCs from Dectin-1 KO and Dectin-2
KO mice.
The Hemocyanin-Mediated
Proinflammatory Response Is Independent
of Dectin-1 and Dectin-2
Next, we investigated whether the proinflammatory effects
of hemocyanins on APCs, such as proinflammatory cytokine
secretion and maturation, were associated with Dectin-1 or
Dectin-2. Therefore, APCs from Dectin-1 KO and Dectin-2
KO mice that had been previously genotypified were cultured
with each hemocyanin for 24 h to analyze IL-12p40 and IL-6
secretion as well as expression of maturation markers (i.e., CD40,
CD80 and CD86) and MHC-I and MHC-II upregulation. In
peritoneal macrophages from both Dectin-1 KO and Dectin-
2 KO mice, IL-12p40 and IL-6 production was comparable to
that in cells from WT mice (Figures 2A,B, respectively). No
difference was observed for hemocyanins in the case of IL-12p40
secretion from Dectin-1 KO BMDCs (Figure 2C). Likewise, a
decreasing trend in IL-12p40 secretion was observed after KLH
and FLH treatment in Dectin-2 KO BMDCs compared with
the secretion from WT BMDCs. Additionally, LPS treatment
induced a significant decrease in IL-12p40 secretion from
Dectin-2 KO BMDCs compared with WT BMDCs (Figure 2C).
Moreover, IL-6 secretion from Dectin-1 KO and Dectin-2 KO
BMDCs was similar to that fromWT BMDCs for all hemocyanin
treatments (Figure 2D).
Furthermore, KLH and FLH significantly increased MHC-I
expression in WT BMDCs compared with negative control
(PBS)-treated BMDCs, but this change was not related to
either Dectin-1 or Dectin-2 expression (Figure 3A). Similarly,
KLH and FLH tended to enhance MHC-II expression in WT
BMDCs; however, this increase was equivalent in dendritic cells
from both Dectin-1 KO and Dectin-2 KO mice (Figure 3B).
Finally, KLH and FLH slightly activated the expression of the
costimulatory molecule CD86 in WT BMDCs, and similar
effects were observed in Dectin-1 KO and Dectin-2 KO BMDCs
(Figure 3C). However, KLH and FLH did not result in an
increase in the costimulatory molecules CD40 and CD80
(Figures 3D,E, respectively). In contrast, CCH induced a limited
increase in MHC-I relative to that induced by the negative
control (PBS) (Figure 3A), but it did not affect MHC-II or
the expression of the maturation markers CD86, CD40, and
CD80 (Figures 3B– E, respectively). The positive control (LPS)
increased the expression of MHC-I and MHC-II as well as the
maturation markers in all assessed conditions (Figure 3). These
results were further confirmed using a fibroblast cell line NIH3T3
stably transfected with either Dectin-1 or Dectin-2 and FcRγ
(58). After 1 h of incubation with hemocyanins labeled with
Alexa Fluor 594, cells overexpressing these receptors did not
exhibit increased uptake of labeled hemocyanins compared to the
respective control NIH3T3 cell lines (Supplementary Figure 1).
These data indicate that Dectin-1 and Dectin-2 are not
endocytic receptors for hemocyanins. Taken together, these
results, show that Dectin-1 and Dectin-2 are not the key
receptors responsible for triggering the hemocyanin-mediated
proinflammatory effects in APCs. However, these results do
not eliminate a role for other Syk-coupled CLRs, and thus
we explored whether those glycoproteins could trigger the Syk
kinase pathway.
Hemocyanins do not Activate the Syk
Kinase Pathway but Trigger the ERK1/2
Kinase Pathway
To complement our previous results, we investigated the role
of Syk kinase in hemocyanin-mediated activation of APCs,
so IL-12p40 and IL-6 secretion at 24 h was analyzed in
WT BMDCs pretreated with the pharmacologic Syk kinase
inhibitors piceatannol and BAY 61-3606. IL-12p40 secretion
induced by FLH was practically abrogated in cells treated with
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FIGURE 1 | Glycan-dependent binding in vitro of hemocyanins to chimeric Dectin-1 and Dectin-2. Indirect ELISA binding curves of KLH (A), CCH (B), and FLH (C) to
the chimeric Dectin-1-Fc receptor. Polystyrene ELISA plates were incubated with increasing concentrations of native or deglycosylated hemocyanins (0.5–10µg/mL in
PBS, pH 7.2) and then the plates were incubated with chimeric Dectin-1-Fc receptor (2.5µg/mL) diluted in TBS buffer. Receptor binding was revealed using an
anti-human IgG ALP-conjugated antiserum; subsequently, pNPP was added. The plates were read at 405 nm. (D) Comparison in the binding of Dectin-1 to native and
deglycosylated hemocyanins. The bar graph represents the binding of Dectin-1 to 10µg/mL of each tested hemocyanin. Zymosan A (Zym) was used as positive
binding control and gelatin as negative binding control. Indirect ELISA binding curves of KLH (E), CCH (F), and FLH (G) to the chimeric Dectin-2-Fc receptor
(2µg/mL) under the same conditions described above. (H) Comparison of the binding of Dectin-2 to native and deglycosylated hemocyanins. The bar graph
represents the binding of 10µg/mL of each tested hemocyanin to Dectin-2. Furfurman was used as a positive binding control and gelatin as negative binding control.
For all graphs, black circles represent native hemocyanins, red squares represent chemically deglycosylated hemocyanins, and blue triangles represent enzymatically
N-deglycosylated hemocyanins. Gray bars and white bars represent the positive and negative binding control, respectively. Data are presented as the mean ± SEM of
two independent experiments. Statistical analyses were performed by two-way ANOVA followed by the Bonferroni posttest. Native hemocyanin vs. chemically or
N-deglycosylated hemocyanin: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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FIGURE 2 | Proinflammatory cytokine secretion induced by hemocyanins is independent of Dectin-1 and Dectin-2. Assessment of IL-12p40 (A) and IL-6 (B) secretion
from peritoneal macrophages from WT (black bars), Dectin-1 KO (red bars) and Dectin-2 KO (blue bars) mice treated with PBS, 1 mg/mL KLH, 1 mg/mL CCH, 1
mg/mL FLH or 1µg/mL LPS (from Salmonella enterica) for 24 h. Supernatants were collected and analyzed by ELISA for cytokine secretion. Assessment of IL-12p40
(C) and IL-6 (D) secretion from BMDCs from WT (black bars), Dectin-1 KO (red bars) and Dectin-2 KO (blue bars) mice treated for 24 h with the same stimuli
described in (A,B). Supernatants were collected and analyzed by ELISA for cytokine secretion. Data are presented as the mean ± SEM of at least three independent
experiments. Statistical analyses were performed by two-way ANOVA followed by the Bonferroni posttest. WT vs. Dectin-1 KO or Dectin-2 KO: *p < 0.05; ns = not
significant.
piceatannol and partially reduced in those treated with BAY
61-3606 (Figures 4A,C, respectively). Similarly, IL-6 secretion
induced by FLH was almost abolished after cotreatment with
both inhibitors (Figures 4B,D). As expected, zymosan-induced
proinflammatory cytokine secretion was diminished by both
inhibitors (Figure 4). Surprisingly, LPS treatment showed a trend
toward a decreased proinflammatory cytokine secretion with
both inhibitors, with a significant decline in IL-6 levels in
cells treated with BAY 61-3606 (Figure 4D). Nevertheless, upon
assessment of Syk kinase phosphorylation via Western blot, we
observed that FLH treatment of WT BMDCs did not induce
Syk kinase activation acutely, unlike treatment with the positive
control zymosan (Figure 4E). These results were assessed using
densitometry image analysis (Figure 4F) and were replicated
over shorter stimulation times with FLH as well as with KLH
by Western blot and FACS (data not shown). The data showed
that Syk kinase inhibition impaired proinflammatory cytokine
secretion, but no Syk kinase phosphorylation was detected
after hemocyanin treatment of APCs. Taken together, these
findings suggest that hemocyanins do not directly activate Syk-
coupled CLRs, supporting the stimulation of alternative signaling
pathways such as those mediated by TLRs.
In contrast, previous data have shown that KLH triggers
ERK1/2 phosphorylation in a human monocytic cell line (34).
Therefore, we conducted Western blotting analyses as well as
those using the selective ERK pharmacologic inhibitor FR180204
to investigate whether hemocyanins could activate the ERK1/2
kinase pathway in BMDCs and peritoneal macrophages from
WT mice. We observed a significant induction of ERK1/2
phosphorylation in BMDCs after an acute incubation with
FLH at 30min and KLH at 10min (Figure 5A). Additionally,
significant induction was observed in macrophages incubated
with FLH at 30min (Figure 5C), suggesting the involvement
of TLR in the response to hemocyanin-mediated activation of
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FIGURE 3 | Upregulation of maturation markers induced by hemocyanin treatment is independent of Dectin-1 and Dectin-2. BMDCs from WT (black bars), Dectin-1
KO (red bars) and Dectin-2 KO (blue bars) mice treated with PBS, 1 mg/mL KLH, 1 mg/mL CCH, 1 mg/mL FLH or 1µg/mL LPS (from Salmonella enterica) for 24 h
(Continued)
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FIGURE 3 | and then analyzed by FACS. (A) Representative histograms of MHC-I (H-2Kb) expression after each treatment. The MHC-I mean fluorescence intensity is
presented as the mean ± SEM of four independent experiments. (B) Representative histograms of MHC-II (I-Ad and I-Ed) expression after each treatment. The
MHC-II mean fluorescence intensity is presented as the mean ± SEM of three independent experiments. (C) Representative histograms of CD86 expression after
each treatment. The CD86 mean fluorescence intensity is presented as the mean ± SEM of two independent experiments. (D) Representative histograms of CD40
expression after each treatment. The CD40 mean fluorescence intensity is presented as the mean ± SEM of two independent experiments. (E) Representative
histograms of CD80 expression after each treatment. The CD80 mean fluorescence intensity is presented as the mean ± SEM of three independent experiments.
Statistical analyses were performed using the paired or unpaired Student’s t-test to compare PBS vs. KLH, CCH, FLH, or LPS: #p < 0.05, ##p < 0.01, ###p < 0.001.
To compare WT vs. Dectin-1 KO or Dectin-2 KO, two-way ANOVA followed by the Bonferroni posttest was performed: ns = not significant.
APCs. These results were assessed using a densitometry image
analysis (Figures 5B,D, respectively). Moreover, a significant
reduction in IL-12p40 and IL-6 secretion induced only by
FLH was observed when BMDCs were cultured with the ERK
inhibitor FR180204 with respect to the control (Figures 5E,F,
respectively). In addition, the effect of pharmacologic inhibitors
on other MAP kinases was analyzed, such as p38 mitogen-
activated protein kinase (p38) and c-Jun N-terminal kinase
(JNK). As shown in Figures 5G,H, the SB203580 inhibitor of
p38 decreased the secretion of IL-6 induced by hemocyanins.
Likewise, a significant decline in the secretion of IL-12p40 was
observed with the JNK inhibitor SP600125 for all hemocyanins
(Figures 5I,J, respectively). Collectively, these results suggest
that the TLR pathways participate in the hemocyanin-mediated
proinflammatory response because ERK1/2, p38 and JNK are
directly involved in the signaling pathway of several Toll-like
receptors such as TLR4 (59).
Hemocyanin Binding in vitro to TLR4 Is
Glycan-Dependent
As a first approximation for TLR4 involvement in hemocyanin
recognition, an ELISA similar to the one described above
for Dectin-1 or Dectin-2 was performed, using increasing
concentrations of native hemocyanins (1 to 20µg/mL) to
evaluate the binding of Fc chimeric TLR4 receptor. The results
showed that KLH, CCH and FLH bound to TLR4 in a dose-
dependent manner (Figures 6A–C, respectively; black circles).
This hemocyanin binding was glycan-dependent because it
decreased with chemically (red squares) and enzymatically
(blue triangles) deglycosylated hemocyanins. The results are
summarized in Figure 6D, in which the binding of hemocyanins
to TLR4 was analyzed at a single representative hemocyanin
concentration (10µg/mL). A significant decrease in the binding
of chemically deglycosylated (red bars) and N-deglycosylated
(blue bars) with respect to native hemocyanins (black bars)
was observed. LPS, the canonical agonist of TLR4, was used
as positive control. The results showed a glycan-dependent
binding of hemocyanins to this receptor in vitro. Taken
together, these data and the previous results for ERK1/2
activation with FLH suggest a probable role for TLR4 in
the hemocyanin-induced proinflammatory effect on APCs.
Therefore, in the subsequent experiments, we decided to evaluate
TLR4 participation, using only FLH because it is the most potent
and consistent hemocyanin in our experimental conditions and
its proinflammatory effects in all APCs cultures have been
demonstrated (5, 10, 30).
TLR4 Is Required to Induce
Hemocyanin-Mediated Proinflammatory
Effects in APCs
Since hemocyanins interact with TLR4 in vitro, we investigated
the involvement of this receptor in the hemocyanin-induced
proinflammatory effects in APCs. TLRs signal through several
adapter molecules such as MyD88, Mal (MyD88 adapter-like,
or also known as TIRAP), TRIF and TRAM to generate a
cellular activation response (60). Considering that Mal protein
was initially described as a signaling adaptor downstream of
TLR4 and TLR2 (61, 62), we assessed whether Mal-deficient
BMDCs showed an impaired effect in response to hemocyanins.
BMDCs from Mal KO mice were treated with FLH for 24 h,
and their cytokine secretion was compared to that of BMDCs
fromWT mice. We found that IL-12p40 and IL-6 secretion were
significantly diminished in Mal KO-derived compared with WT
cells (Figures 7A,B, respectively). Moreover, ligands for TLR4
(LPS) and TLR2 (Pam3CysK4) showed an impaired effect in these
cells, in contrast to the ligand for TLR9 (CpG), which showed
an equivalent effect relative to that of WT cells (Figures 7A,B).
These data supported the participation of the TLR pathway in
the proinflammatory effects of mollusk hemocyanins in APCs.
Since cytokine secretion induced by hemocyanins was impaired
in Mal KO BMDCs, we investigated whether TLR4 was required
to trigger the hemocyanin-mediated proinflammatory response
of APCs. Hence, we established the involvement of TLR4 using
BMDCs from C3H/HeJ mice, a strain that carries a specific
mutation in the TLR4 gene that impairs its normal function
(63). BMDCs derived from C3H/HeJ mice were significantly less
stimulated by FLH than those from the control strain C3H/HeN,
as IL-12p40 and IL-6 levels were significantly reduced in the
BMDCs carrying themutated TLR4 (Figures 7C,D, respectively).
Taken together, these results suggest that TLR4 participates in
the hemocyanin-induced proinflammatory effects in antigen-
presenting cells.
Thus, to confirm the involvement of TLR4 in the FLH-
mediated proinflammatory response, we developed studies with
a blocking TLR4 monoclonal antibody on APCs. First, we
determined the appropriate concentration of anti-TLR4 antibody
to inhibit IL-12p40 and IL-6 secretion induced by FLH in
cell culture supernatants (data not shown). Then, APCs were
preincubated with anti-TLR4 antibody or an isotype control
antibody (10µg/mL) and subsequently stimulated with FLH;
culture medium and LPS were used as negative and positive
controls, respectively. The results showed a significant decrease
in IL-12p40 and IL-6 secretion in BMDCs (Figures 7E,F)
in comparison to the cytokine level of the isotype control
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FIGURE 4 | Hemocyanins do not directly activate the Syk kinase pathway in BMDCs. Assessment of IL-12p40 (A) and IL-6 (B) secretion from BMDCs from WT mice
preincubated for 30min with 20µM of Syk inhibitor piceatannol or control treatment followed by 24 h of incubation with PBS, 1 mg/mL KLH, 1 mg/mL CCH, 1 mg/mL
FLH, 10µg/mL Zymosan A (Zym) or 1µg/mL LPS (from E. coli). Supernatants were collected, and cytokine secretion was quantified by ELISA. Data are presented as
the mean ± SEM of two independent experiments. Assessment of IL-12p40 (C) and IL-6 (D) secretion from BMDCs from WT mice preincubated for 30min with 1µM
of the Syk inhibitor BAY 61-3606 or control treatment followed by 24 h of incubation with the same stimuli described above. Supernatants were collected, and
cytokine secretion was analyzed by ELISA. Data are presented as the mean ± SEM of three independent experiments. Statistical analyses were performed using the
paired Student’s t-test. Control vs. Syk inhibitors: *p < 0.05, **p < 0.01 (E) Western blotting analysis of Syk kinase phosphorylation (Y525/Y526) in BMDCs from WT
mice and incubated with PBS (negative control), 50µg/mL Zymosan A (Zym; positive control) or 1 mg/mL FLH for the indicated time. Data are representative of two
independent experiments with similar results. (F). Densitometry analyses of phospho-Syk (pSyk; expressed as fold induction relative to PBS) after 1 h of incubation
with each treatment based on two independent experiments shown in (E). Statistical analyses were performed using the unpaired Student’s t-test to compare each
condition: *p < 0.05, ns = not significant.
antibody. Concomitantly, a significantly reduced level of these
cytokines induced by LPS was observed. Similar results were
found in peritoneal macrophages (Figures 7G,H). Finally,
to confirm a direct role of TLR4 in the FLH-mediated
proinflammatory response, we used immortalized bone marrow-
derived macrophages from TLR4 KO mice. Accordingly, iBMMs
were cultured for 24 h with FLH and then, we analyzed the
expression levels of IL-6 in the cell culture supernatants; the
same controls described above were used. The results showed that
IL-6 secretion was almost abolished compared to that from WT
macrophages (Figure 7I). Therefore, these data demonstrated the
participation of TLR4 in the proinflammatory response triggered
by hemocyanins.
DISCUSSION
Different studies have proposed that oligosaccharides play a role
in the nonspecific immunomodulatory effects of hemocyanins
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FIGURE 5 | MAP kinase pathways are involved in hemocyanin-induced APC activation. (A) Western blotting analysis of ERK1/2 kinase phosphorylation (T202/Y204)
in BMDCs from WT mice incubated with 1 mg/mL FLH or 1 mg/mL KLH for the indicated time. Unstimulated cells were used as a negative control and 100 ng/mL
LPS (from E. coli) as positive control. Data are representative of three independent experiments with similar results. (B) Densitometry quantification of
phospho-ERK1/2 (pERK1/2; expressed as fold induction relative to negative control) of three independent experiments shown in (A). Statistical analyses were
performed using the unpaired Student’s t-test to compare the negative control vs. treatment: *p < 0.05, **p < 0.01. (C) Western blotting analysis of ERK1/2 kinase
phosphorylation (T202/Y204) in peritoneal macrophages from WT mice incubated under the same conditions described in (A). Data are representative of three
independent experiments with similar results. (D) Densitometry quantification of phospho-ERK1/2 (pERK1/2; expressed as fold induction relative to negative control)
of three independent experiments shown in (C). Statistical analyses were performed using the unpaired Student’s t-test to compare the negative control vs. treatment:
*p < 0.05, **p < 0.01, ****p < 0.0001. Assessment of IL-12p40 (E) and IL-6 (F) secretion by BMDCs from WT mice preincubated for 1 h with 100µM of ERK1/2
inhibitor FR180204 or control treatment, followed by 24 h of incubation with 1 mg/mL KLH, 1 mg/mL CCH, 1 mg/mL FLH or 100 ng/mL LPS (from E. coli).
Unstimulated cells were used as a negative control. Supernatants were collected, and cytokine secretion was quantified by ELISA. Data are presented as the mean ±
SEM of four independent experiments. Assessment of IL-12p40 (G) and IL-6 (H) secretion by BMDCs from WT mice preincubated for 1 h with 100µM of p38 inhibitor
SB203580 or control treatment, followed by 24 h of incubation under same conditions described in (E,F). Supernatants were collected, and cytokine secretion was
(Continued)
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FIGURE 5 | quantified by ELISA. Data are presented as the mean ± SEM of four independent experiments. Assessment of IL-12p40 (I) and IL-6 (J) secretion by
BMDCs from WT mice preincubated for 1 h with 20µM of JNK inhibitor SP600125 or control treatment followed by 24 h of incubation under same conditions
described in (E,F). Supernatants were collected, and cytokine secretion was quantified by ELISA. Data are presented as the mean ± SEM of five independent
experiments. Statistical analyses were performed using unpaired Student’s t-test to compare control vs. MAP kinase inhibitors: *p < 0.05, **p < 0.01, ***p < 0.001,
****p <0.0001.
FIGURE 6 | Glycan-dependent binding of hemocyanins to TLR4 in vitro. Indirect ELISA binding curves of KLH (A), CCH (B), and FLH (C) to chimeric TLR4-Fc
receptor. Polystyrene ELISA plates were incubated with increasing concentrations of native or deglycosylated hemocyanins (1–20µg/mL in PBS, pH 7.2), and then
the plates were incubated with chimeric TLR4-Fc receptor (1µg/mL) diluted in TBS buffer. Binding was revealed using an anti-mouse IgG ALP-conjugated antiserum;
subsequently, pNPP was added. The plates were read at 405 nm. (D) Comparison of the binding of chimeric TLR4 to native and deglycosylated hemocyanins. The
bar graph represents the binding of TLR4-Fc to 10µg/mL of each tested hemocyanin. LPS (from E. coli) was used as a positive binding control, and gelatin served as
negative binding control. Black circles represent native hemocyanins, red squares represent chemically deglycosylated hemocyanins, and blue triangles represent
enzymatically N-deglycosylated hemocyanins. Gray and white bars represent the positive binding and negative binding control, respectively. Data are presented as the
mean ± SEM of three independent experiments. Statistical analyses were performed by two-way ANOVA followed by the Bonferroni posttest. Native hemocyanin vs.
chemically or N-deglycosylated hemocyanin: *p < 0.05, **p < 0.01, ****p < 0.0001.
(10, 15, 18, 25). However, to date, there is limited evidence to
support this hypothesis. In this respect, we demonstrated that
FLH deglycosylation abolished the FLH-induced maturation of
murine DCs and attenuated their antitumoral effects in a mouse
melanoma model (10). Furthermore, the experiments conducted
by Presicce et al. (32) showed that KLH-mediated activation of
human DCs was partially inhibited by blocking MR. Moreover,
our previous studies showed that KLH, CCH, and FLH bind to
human MR in vitro with high affinity constants and participate
in hemocyanin endocytosis in murine macrophages (30, 33).
These data strongly suggest that the innate immune receptors
localized on APCs, which bind to sugar moiety-containing
proteins such as CLRs and TLRs, can recognize carbohydrate
structures on hemocyanins and, in this way, initiate the immune
response against them. We hypothesized that APCs recognize
hemocyanins as a “highly mannosylated molecular pattern”
because of specific glycan moieties that these proteins share
with characteristic pathogens (30). Consequently, the aim of
this study was to identify new receptors and signaling pathways
involved in the beneficial proinflammatory effects induced by
KLH, CCH, and FLH in APCs (including dendritic cells and
macrophages) from mice. The receptors proposed for this
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FIGURE 7 | TLR4 participates in hemocyanin-induced proinflammatory cytokine secretion in APCs. Assessment of IL-12p40 (A) and IL-6 (B) secretion by BMDCs
from WT and Mal KO mice. BMDCs were incubated for 24 h with PBS, 1 mg/mL FLH, TLR4 control E. coli LPS (10 ng/mL), TLR2 control Pam3CysK4 (1µg/mL) or
TLR9 control CpG (4µg/mL). Cytokine production was analyzed by ELISA. Data are presented as the mean ± SEM of three independent experiments. Statistical
analyses were performed by two-way ANOVA followed by the Bonferroni posttest. WT vs. KO: **p < 0.01, ***p < 0.001, ****p < 0.0001. Assessment of IL-12p40
(C) and IL-6 (D) secretion by BMDCs from C3H/HeN mice (TLR4 WT) and C3H3/HeJ mice (TLR4 mutant). BMDCs were incubated with increasing concentrations of
FLH (0.1, 0.5 and 1 mg/mL) for 24 h. Cytokine production was analyzed by ELISA. Data are presented as the mean ± SEM of at least two independent experiments.
(Continued)
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FIGURE 7 | Statistical analyses were performed by two-way ANOVA followed by the Bonferroni posttest. C3H/HeN vs. C3H/HeJ at the respective FLH concentration:
***p < 0.001, ****p < 0.0001. Blocking anti-TLR4 antibody inhibits IL-12p40 (E) and IL-6 (F) production in BMDCs. Cells were preincubated for 1 h with 10µg/mL of
anti-TLR4 monoclonal antibody or isotype control, and then 1 mg/mL FLH or 10 ng/mL LPS from E. coli was added for 24 h. Cytokine secretion was analyzed by
ELISA. Data are presented as the mean ± SEM of three independent experiments. Blocking anti-TLR4 antibody inhibits IL-12p40 (G) and IL-6 (H) production in
peritoneal macrophages. Cells were incubated as described in (E,F). Data are presented as the mean ± SEM of three independent experiments. Statistical analyses
were performed using the unpaired Student’s t-test. Isotype control vs. anti-TLR4 antibody: *p < 0.05. (I) IL-6 secretion induced by FLH is impaired in bone
marrow-derived macrophages deficient for TLR4. Cells were incubated for 24 h with PBS, 1 mg/mL FLH, and the TLR4 control E. coli LPS (10 ng/mL). Then,
supernatants were collected and analyzed by ELISA. Data are presented as the mean ± SEM of three independent experiments. Statistical analyses were performed
by two-way ANOVA followed by the Bonferroni posttest. WT vs. TLR4 KO: **p < 0.01, ****p < 0.0001.
response were the CLRs Dectin-1 and Dectin-2, which are
involved in the recognition of cell wall components of fungi
(35–38), and TLR4, which is involved in the recognition of
bacterial cell wall components (39–41). The main results showed
that hemocyanins activated TLR signaling pathways in APCs
via TLR4. However, hemocyanins did not activate Syk-coupled
CLRs, including Dectin-1 and Dectin-2, in APCs.
The results showed that native hemocyanins bound to
chimeric Dectin-1 and Dectin-2 receptors in vitro in a glycan-
dependent manner. Strikingly, chemical deglycosylation of
hemocyanins by periodate oxidation diminished binding to
Dectin-1 but not to Dectin-2. We attributed this result to a
partial removal of glycans by this method, because other internal
sugars could be exposed after treatment, which would explain
the residual binding to Dectin-2 (64, 65). Moreover, enzymatic
deglycosylation of hemocyanins significantly diminished binding
to both receptors. N-deglycosylation with PNGase F achieved
almost total abrogation of hemocyanin binding to Dectin-
2 but a partial loss binding to Dectin-1, suggesting that O-
glycosylations and residual N-glycosylations could be relevant
in this recognition. In addition to these results, peritoneal
macrophages and BMDCs from mice deficient for Dectin-1
or Dectin-2 showed an equivalent secretion of IL-6 and IL-
12p40 and similar upregulation of maturationmarkers compared
with those in WT APCs, confirming that these receptors were
not involved in the proinflammatory effects of hemocyanins.
Surprisingly, in a cellular context, hemocyanin uptake did not
increase in NIH3T3 cell lines overexpressing Dectin-1 or Dectin-
2, demonstrating that the binding with chimeric receptors
reported above does not trigger hemocyanin endocytosis. A
possible explanation for this hemocyanin binding to chimeric
Dectin-1 and Dectin-2 is that the ELISA represented the initial
exploration to find potential ligands. However, the in vitro
interaction does not always lead to a response in reporter cell
lines or KO cells (66). This inconsistency could be explained
by the proper folding of the carbohydrate binding domains in
the chimeric protein, as well as the physicochemical conditions
of the assay, which could facilitate the intrinsic ligand-receptor
interaction in the ELISA. However, this interaction would not
occur when the receptor displays its native folding on the
plasma membrane, where the binding site could be in a different
conformation and even masked by the cellular glycocalyx. In
contrast, a significant difference was found only in the secretion
of IL-12p40 from Dectin-2 KO BMDCs after LPS treatment
(Figure 2C). This result could be explained by the reported
cooperation between TLR4 and Dectin-2 (67).
Unexpectedly, we found that KLH and FLH induced an
upregulation of MHC-I in BMDCs (Figure 3A), suggesting a
role of cross-presentation in the processing of hemocyanins
and consequential induction of CD8+ T cells related to
the antitumor immune response (68). In this context, it
is important to remark that immunohistological studies of
biopsies from superficial bladder cancer patients who underwent
immunotherapy with KLH showed a massive infiltration of
mononuclear cells and CD4+ lymphocytes, as well as, to a
lesser extent, CD8+ lymphocytes and granulocytes (69). In
addition, during immunotherapy with KLH, a CD4+ lymphocyte
response with an increase in CD8+ lymphocytes in the lymphatic
nodules has been observed (70). Whether these results can
be interpreted in the context of a cross-presentation of KLH
has not been addressed. Thus, further studies regarding the
role of sugar moieties on hemocyanins in enhanced MHC-I
expression as well as the capacity to generate CD8+ T cell-
specific responses are necessary to elucidate the antitumor
mechanisms of these glycoproteins.
Yasuda et al. (34) suggested that Syk kinase is activated
after KLH treatment in the human monocyte cell line THP-1.
Nevertheless, these authors did not present data regarding the
phosphorylation status of this kinase after KLH treatment, and
they only reported an inhibitory effect on NF-κB activation
and ERK1/2 phosphorylation after preincubation with the
Syk inhibitor BAY 61-3606. Similarly, our data showed
that Syk phosphorylation was not detected by Western
blot after hemocyanin treatment of APCs (Figure 4E). In
contrast, pharmacological inhibition of Syk kinase with
piceatannol, a wide spectrum inhibitor, and BAY 61-3606,
a more specific inhibitor, diminished the IL-12p40 and IL-6
secretion induced by hemocyanins. An explanation for these
apparent contradictory findings is the off-target effects described
for both pharmacologic inhibitors used (71–73), implying the
limitations of pharmacological tools in the study of signaling
pathways. Indeed, we also observed a diminution of LPS-induced
proinflammatory cytokine secretion with piceatannol and BAY
61-3606. At this point, it has been previously reported that
LPS-mediated activation of APCs is ameliorated by the Syk
inhibitor piceatannol, suggesting that the decrease observed in
hemocyanin treatments with both inhibitors was a nonspecific
inhibition of TLR signaling pathways (74). In addition, we found
that pharmacologic inhibition ofMAP kinases (ERK1/2, p38, and
JNK) impaired hemocyanin-induced proinflammatory cytokine
secretion, suggesting a role for TLR pathways. Moreover,
we showed that ERK1/2 was phosphorylated upon FLH and
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KLH stimulation in DCs and macrophages (Figures 5A,C),
in agreement with the reported effect of KLH in THP-1 cells
(34). Therefore, taken together, these data eliminate Syk-
coupled CLRs in the recognition of hemocyanins and suggest
the involvement of TLRs. Considering these findings, we
evaluated the participation of the TLR signaling pathways in the
hemocyanin-induced proinflammatory effect in APCs.
Our interest was focused on TLR4 and the downstream
signaling adaptor Mal in APCs because of the interaction of
this receptor with glycan patterns expressed by diverse fungi
and Gram-negative bacteria, which induces the production
of NF-κB-dependent proinflammatory cytokines and strongly
drives the immune respond toward Th1 polarization (75). TLR4
recognizes LPS molecules, which exhibit an abundant diversity
in their glycan nature (76). LPS contains a highly variable
region of O-antigen polysaccharide, similar to the glycans present
in hemocyanins (owing to their mannose-rich moieties) (29,
77). TLR4 also participates in the proinflammatory response
induced by mannans from Saccharomyces cerevisiae and Candida
albicans, indicating a glycan recognition beyond LPS structure
(78). In this regard, we reported a glycan-dependent interaction
in vitro of hemocyanins with chimeric TLR4 (Figure 6), which
suggested as we previously shown, a pivotal role of hemocyanin
glycosylations in their beneficial immune responses (10, 43). We
also found a Mal-dependent mechanism of APC activation by
hemocyanins. Indeed, the functional involvement of TLR4 in
the hemocyanin-mediated proinflammatory response in APCs
was supported by several lines of evidence, including the
use of a specific TLR4 blocking monoclonal antibody, by
BMDCs from C3H/HeJ mice, which possess a nonfunctional
mutation in this receptor, and by the evaluation of macrophages
deficient for TLR4. The results of these experiments showed
that APCs display systematically significant decreases in the
levels of IL-12p40 and IL-6 induced by FLH with respect to the
controls (Figure 7).
However, previous studies in C3H/HeJ mice have shown
that both KLH and CCH exhibit antitumor properties against
superficial bladder cancer (79), suggesting the involvement of
another receptor other than TLR4 in the antitumor effect of
hemocyanins. Mal adaptor protein mediates TLR2 and TLR4
signaling (61, 62, 80). Thus, future experiments should focus on
the participation of TLR2 in hemocyanin recognition by APCs.
Indeed, TLR2 is involved in host defense against Cryptococcus
neoformans (81), and antibodies against KLH cross-react with
this pathogen (29).
Remarkably, TLR4 and MR cooperation to trigger
intracellular signaling pathways for cytokine secretion in
response to different mannosylated antigens, has been previously
described (82–84). Mannose receptor plays a role in the APC
response to hemocyanins (30, 32, 33). MR lacks a cytoplasmic
domain to transduce the external signal to intracellular
pathways, which are required to interact with other canonical
pattern recognition receptors to mediate intracellular signaling
networks for the generation of a proinflammatory response in
APCs (85). Therefore, we hypothesize that hemocyanins can
be recognized by various host innate immune receptors due
to the multivalent nature of their glycosylations, leading to
FIGURE 8 | Proposed model of cooperation between MR and TLR4 with
regard to the immunostimulatory effects of hemocyanins on APCs. Schematic
representation showing a possible mechanism of cooperation between
mannose receptor (MR) and TLR4 in the recognition of hemocyanins to initiate
a proinflammatory response against these macromolecules. Based on our
previous studies, we propose that APCs recognize hemocyanin glycosylations
through MR due to their “highly mannosylated molecular patterns”. Then, via
clusters of heterologous pattern recognition receptors (PRR) on the APC
surface, hemocyanins activate TLR4 to stimulate MAP kinase-dependent
downstream signaling pathways. Thus, the cooperation between MR and
TLR4 could contribute to the described proinflammatory effects and
consequent APC activation induced by hemocyanins.
the activation of several signaling molecules of a downstream
target that operate in a complementary manner to induce
distinct cellular responses, as has been described for microbial
ligands (86). Thus, we propose that the hemocyanin-induced
proinflammatory response includes an initial binding to MR
and consequent activation of the TLR signaling pathway. In
the theoretical cooperative mechanism shown in Figure 8,
hemocyanins would activate APCs through the clustering of
pattern recognition receptors (PRRs), involving the direct
interaction with MR and cooperation with TLR4 to induce
signaling pathways that generate a beneficial proinflammatory
milieu. These hemocyanin-induced proinflammatory effects in
APCs induce a beneficial bystander effect, which directs the
immune response toward Th1 polarization.
It is important to note that in the comparison of
the hemocyanins used herein, FLH showed the greatest
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immunological effects, as reflected in the quantitative differences
in cytokine secretion by APCs, corroborating previous data
showing its superior immunomodulatory activity compared
with CCH and KLH (10). Indeed, macrophages stimulated
with FLH showed an elevated M1 transcript cytokine profile
compared with macrophages stimulated with CCH or KLH,
fully supporting the notion that the cytokine gene expression
profile and cytokine protein secretion induced by CCH, FLH and
KLH are significantly different in intensity and temporality for
each one (30). Certainly, together these data support potential
mechanisms, but they do not provide evidence concerning the
cause of these differences, which could be explained, in part,
by the hemocyanin binding to MR and TLR4 with different
affinities, depending of the oligosaccharides (number, type, and
substitution patterns of outer sugar branches) on the protein,
leading to differential production of proinflammatory cytokines.
Additionally, the different strains used herein showed variations
in the levels of cytokines secretion induced by FLH, despite
having the same genes, which probably explains the phenotypic
differences (87, 88). These genetic background influences have
been reported in different inflammatory processes involving
TLR4 (89, 90). In this context, we think that host genetic
variations and TLR4 signaling could determine the immune
response to FLH via modulation of cytokine production. In
support of this idea, the early studies of Cerottini and Unanue
(91) showed clear differences in the immune responses of
different mouse strains to KLH.
Finally, it is relevant to mention that, although a large
and compelling body of evidence has shown the valuable
clinical outcomes of hemocyanins, remarkably, the molecular
and cellular bases of their immunostimulatory activities are
scarcely known. In this context, we believe that the present
study represents a significant contribution to the knowledge
of the immunostimulatory mechanisms of hemocyanins
in mammals. From a basic science perspective, a detailed
molecular understanding of the receptors and signaling
pathways involved in hemocyanin-induced immunostimulatory
processes in mammals, will be required to support new
strategies to more effectively boost antitumor immunity in
adoptive immunotherapy strategies utilizing these glycoproteins.
Indeed, hemocyanins are natural, nontoxic, nonpathogenic
immunostimulants that exert their effects as immunopotentiators
without the unwanted inflammatory side effects of classical
adjuvants that drive cell-mediated immune responses, thus
making them ideal for long-term on-going treatments (3, 92–
94). For instance, KLH has been approved in the superficial
bladder cancer treatment, as alternative to BCG (Bacillus
Calmette–Guérin) arguing these reasons (6, 95). Although there
are more potent adjuvants than hemocyanins, most of them are
from Gram negative bacteria and emulsions such as Montanide,
their toxicity is perhaps the single most important impediment
to introduce them to human use (96, 97). Thus, it is necessary
to provide effective and safe alternative adjuvants, such as
hemocyanins, whose properties could be partially explained as a
carbohydrate-based adjuvant (98), beyond to be a protein-based
antigen. Considering that innate immune signals modulate not
only the magnitude of the adaptive response but also the quality
of this response, hemocyanins as carbohydrate-based adjuvants
could act giving a signal at level of antigen recognition and
APC activation as a TLR4 agonist (signal 0) (99), acting in a
synergistic way with the mannose receptor. Indeed, most specific
adjuvants, such as TLR agonists act on signal 0, and indirectly by
activating APCs and triggering the secretion of proinflammatory
cytokines (signal 1), favoring efficient presentation of the
co-administered antigen. In addition, hemocyanins do not
target costimulatory molecules (signal 2), so over-stimulation
would not be a problem. Remarkably, we have also shown that
hemocyanins can be used in combination with other adjuvants,
lowering their dosage and reducing their cytotoxicity as the
case of AddaVax (5) and saponin QS-21 (94), used to enhance
the immunogenicity of cancer vaccines. In conclusion, our data
show that TLR4 participates in the proinflammatory effects
induced by hemocyanins in APCs of mammals. By contrast, the
effects in APCs induced by hemocyanins are independent of the
CLRs Dectin-1 and Dectin-2, despite the ability of hemocyanins
to bind to both receptors in vitro. Thus, the data reported in the
present study suggest a potential mechanism by which APCs
respond to hemocyanins.
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